Soft Tissue Sarcoma
📧 Sign up to get email alerts when something new happens for Soft Tissue Sarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-05-14Clinical Trial Update: Efficacy and Safety of Anlotinib in Adjuvant Therapy for High-grade Soft Tissue Sarcoma [Phase 2]
Phase 2 results assess the efficacy and safety of anlotinib as adjuvant therapy for high-grade soft tissue sarcoma.
-
CLINICAL_TRIALS trial_result · 2025-05-13Clinical Trial Update: tislelizUMaB in canceR Patients With molEcuLar residuaL Disease [Phase 3]
Phase 3 trial evaluating tislelizumab in cancer patients with molecular residual disease is currently recruiting.
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: Brachytherapy (Iodine-125 Seeds) and Fluzoparib Combination Therapy for Advanced Unresectable Soft Tissue Sarcoma [Phase 2]
A Phase 2 clinical trial is evaluating the combination of brachytherapy using iodine-125 seeds with the PARP inhibitor fluzoparib for advanc…
-
CLINICAL_TRIALS trial_result · 2025-05-08Clinical Trial Update: Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors [Phase 1, Phase 2]
The Phase 1/2 trial of surufatinib in combination with tislelizumab for advanced solid tumors has been terminated. Results were posted on 20…
-
CLINICAL_TRIALS research · 2025-05-04Clinical Trial Update: Gemcitabine Plus Ascorbate for Sarcoma in Adults (Pilot) [EARLY_Phase 1]
Early-phase 1 clinical trial evaluating gemcitabine plus high-dose ascorbate for sarcoma in adults is active but not recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-05-02Clinical Trial Update: Collecting and Storing Tissue From Young Patients With Cancer
A completed clinical trial update from the Children’s Oncology Group describing the collection and storage of tissue from pediatric cancer p…
-
CLINICAL_TRIALS trial_result · 2025-05-02Clinical Trial Update: A Study of LY2880070 in Participants With Advanced or Metastatic Cancer [Phase 1, Phase 2]
Esperas Pharma completed a Phase 1/2 study of LY2880070 in adults with advanced or metastatic cancer, including colorectal cancer.
-
CLINICAL_TRIALS trial_result · 2025-04-30Clinical Trial Update: Radiotherapy With Hyperthermia in Recurrent and Radiation-Induced Sarcomas [NA]
A completed clinical trial evaluating the combination of radiotherapy with hyperthermia for recurrent soft tissue sarcoma and radiation-indu…
-
CLINICAL_TRIALS research · 2025-04-29Clinical Trial Update: APX005M and Doxorubicin in Advanced Sarcoma [Phase 2]
A Phase 2 clinical trial evaluating APX005M in combination with doxorubicin for advanced soft tissue sarcoma is currently active but not rec…
-
CLINICAL_TRIALS research · 2025-04-04Clinical Trial Update: tTF-NGR Randomized Study - STS [Phase 3]
Phase 3 randomized study evaluating tTF-NGR for soft tissue sarcoma is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-04-04Clinical Trial Update: Phase II Trial of Ribociclib and Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS) [Phase 2]
Phase II clinical trial evaluating ribociclib in combination with everolimus in advanced dedifferentiated liposarcoma and leiomyosarcoma; th…
-
EMA approval · 2025-04-03EMA Authorised: Yondelis (trabectedin) — Pharma Mar S.A.
EU marketing authorisation granted for Yondelis (trabectedin) for ovarian neoplasms and soft tissue sarcoma.
-
CLINICAL_TRIALS trial_result · 2025-04-03Clinical Trial Update: Chiauranib for Advanced or Unresectable Soft Tissue Sarcoma(STS) [Phase 2]
Phase 2 trial of Chiauranib for advanced or unresectable soft tissue sarcoma has completed.
-
CLINICAL_TRIALS research · 2025-03-28Clinical Trial Update: Hypofractionated Radiotherapy Followed by Surgical Resection in the Treatment of Soft Tissue Sarcomas [Phase 2]
This ClinicalTrials.gov entry describes a Phase 2 trial evaluating hypofractionated radiotherapy followed by surgical resection for soft tis…
-
CLINICAL_TRIALS research · 2025-03-25Clinical Trial Update: Comparison of Oral Cyclophosphamide vs Doxorubicin in ≥65 Years Old Advanced or Metastatic Soft Tissue Sarcoma Patients [Phase 3]
Phase 3 trial comparing oral cyclophosphamide versus doxorubicin in patients aged 65 and older with advanced or metastatic soft tissue sarco…
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: Multicohort Trial of Different Schemes of PM14 in Monotherapy and in Combination with Radiotherapy in Soft Tissue Sarcomas and Other Solid Tumor [Phase 1, Phase 2]
Multicohort Phase 1/2 clinical trial evaluating PM14 as monotherapy and in combination with radiotherapy for soft tissue sarcoma and other s…
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: Observational Study, for Quality Assessment, of Sarcoma in European and Latin American Multidisciplinary NETWORK
An observational quality-assessment study of sarcoma being conducted across European and Latin American multidisciplinary networks; recruitm…
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: SAVE Studie- SArcoma Surgery With Vacuum Enhanced Wound Treatment Randomised Study to Evaluate the Wound Management in Sarcoma Surgery [NA]
A clinical trial evaluating vacuum-enhanced wound treatment for sarcoma surgery is currently recruiting at Universitätsklinikum Hamburg-Eppe…
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: Soft Tissue Sarcoma: Motor Performance, Robotic Rehabilitation, Nutrition, and Quality of Life [NA]
This clinical trial update reports a study on soft tissue sarcoma evaluating motor performance, robotic rehabilitation, nutrition, and quali…
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: Radiation Therapy to Treat Musculoskeletal Tumors [Phase 2]
A Phase 2 clinical trial evaluating radiation therapy for musculoskeletal tumors has posted results (as of 2025-03-06). The study is current…
-
CLINICAL_TRIALS research · 2025-02-27Clinical Trial Update: Umbilical Cord Blood NK Cell Therapy for High-Risk Pediatric Soft Tissue Sarcoma: Efficacy and Safety Study [NA]
This clinical trial update reports on a study of umbilical cord blood-derived natural killer (NK) cell therapy for high-risk pediatric soft …
-
CLINICAL_TRIALS research · 2025-02-24Clinical Trial Update: SAINT:Trabectedin, Ipilimumab and Nivolumab for Previously Treated Advanced Soft Tissue Sarcoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial update evaluating the triple combo of trabectedin, ipilimumab, and nivolumab in previously treated advanced or me…
-
CLINICAL_TRIALS research · 2025-02-24Clinical Trial Update: Evaluation of AL3818 in Combination With Nivolumab in Solid Tumors [Phase 1, Phase 2]
Clinical trial update on a Phase 1/2 study evaluating AL3818 in combination with nivolumab for solid tumors; the trial is currently not recr…
-
CLINICAL_TRIALS withdrawal · 2025-02-24Clinical Trial Update: A Phase 2 Study Using Aliya PEF Plus Pembro for Sarcoma [Phase 2]
Phase 2 study of Aliya PEF Plus pembrolizumab for soft tissue sarcoma has been withdrawn.
-
CLINICAL_TRIALS research · 2025-02-24Clinical Trial Update: Metronomic Trabectedin, Gemcitabine, and Dacarbazine for Soft Tissue Sarcoma [Phase 2]
A Phase 2 clinical trial update evaluating metronomic dosing of a three-drug combination (trabectedin, gemcitabine, and dacarbazine) for lei…